The generic drugs market value is projected to grow from USD 414.56 billion in 2021 and is projected to reach USD 574.63 billion by 2027, growing at a CAGR of 5.59% from 2021 to 2027.
The report contains 180+ pages with detailed analysis. The market report also covers the estimated market sizes and trends for different countries across major regions, globally.
Generic Drugs smashes the drug industry market with record growth and sustainable market trend making it a lucrative area to operate in.
A generic drug comprises the same chemical substance as a drug that was previously protected by a chemical patent. After the patents on the original pharmaceuticals expire, generic drugs can be sold. The medical profile of generics is thought to be equal in performance because the active chemical ingredient is the same. Generic medicine contains the same active pharmaceutical ingredient (API) as the brand-name drug, but it may change in terms of manufacturing technique, formulation, excipients, color, taste, and packaging. The cost effectiveness of generic drugs has contributed for a competitive advantage over the branded drugs is the prime factor adding boost to the market growth.
Crucial factors accountable for market growth are:
- The low cost of generics as an alternative to branded drugs
- A large number of patents expired branded drugs
- Initiatives by governments and other regulatory bodies across the globe
Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1205
Research Objective
the market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2017 to 2020. This research report evaluates generic drugs market on a global and regional level. It offers thorough analysis of market status, growth and forecast of the global generic drugs market for the period from 2017 to 2027. This research study offers historic data for years 2017 to 2020 along with a forecast from 2021 to 2027 based on value.
This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the generic drugs market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Report Scope of the Generic Drugs Market
| Report Highlights | Details |
| Market Size | US$ 574.63 Billion by 2027 |
| Growth Rate | CAGR of 5.7% From 2021 to 2027 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2027 |
| Segments Covered | Drug, Brand, Route of Drug Administration, Therapeutic Application, Distribution Channel |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
KEY HIGHLIGHTS OF THE STUDY
- The oral segment of route of administration is estimated to grow at the remarkable rate and accounted the largest share throughout the study period.
- Branded generics dominate the generic drugs market in 2020, however pure generics is anticipated to surpass branded generics by 2027.
- Asia Pacific region is projected to grow at the fastest CAGR during the forecast period owing to the rapid penetration of local players in the market.
- North America dominated the generic drugsmarket and is projected to retain its trend throughout the forecast period.
- Cardiovascular of the therapeutic application segment exhibited major revenue share in the year 2020, whereas, oncology segment poised to grow at the fastest rate during the foresee future.
- Retail pharmacy holds the leading position in distribution channel segment; however, online distribution is growing at the significant pace during the forecast period.
Top Players contending in the Market:
- Mylan N.V.
- Abbott Laboratories
- ALLERGAN
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- STADA Arzneimittel AG
- GlaxoSmithKline Plc.
- Baxter International Inc.
- Pfizer Inc.
- Sandoz International GmbH
Major Market Segments Covered:
By Brand
- Pure generic drugs
- Branded generic drugs
By Route of Drug Administration
- Oral
- Topical
- Parental
- Others
By Therapeutic Application
- Central nervous system (CNS)
- Cardiovascular
- Dermatology
- Oncology
- Respiratory
- Others
Key Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Generic Drugs Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Generic Drugs Market
5.1. Covid-19: generic drugs Industry Impact
5.2. generic drugs Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and generic drugs Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for generic drugs Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Generic Drugs Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. The low cost of generics, as an alternative to branded drugs
6.1.1.2. Large number of patent expired branded drugs
6.1.1.3. Initiatives by governments and other regulatory bodies
6.1.2. Market Restraints
6.1.2.1. Stringent governmental regulations and adverse effects associated with drugs
6.1.3. Market Opportunities
6.1.3.1. Use of RPA to ensure regulatory and standards compliance
Chapter 7. Global Generic Drugs Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. generic drugs Market Revenue by Market Players (2017 – 2020)
7.1.1.2. generic drugs Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Generic Drugs Market, By Drug Type
8.1. generic drugs Market, by Drug Type, 2017-2027
8.1.1. Simple Generics
8.1.1.1. Market Revenue and Forecast (2017-2027)
8.1.2. Super Generics
8.1.2.1. Market Revenue and Forecast (2017-2027)
Chapter 9. Global Generic Drugs Market, By Brand
9.1. generic drugs Market, by Brand, 2017-2027
9.1.1. Pure generic drugs
9.1.1.1. Market Revenue and Forecast (2017-2027)
9.1.2. Branded generic drugs
9.1.2.1. Market Revenue and Forecast (2017-2027)
Chapter 10. Global Generic Drugs Market, By Route of Drug Administration
10.1. generic drugs Market, by Route of Drug Administration, 2017-2027
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2017-2027)
10.1.2. Topical
10.1.2.1. Market Revenue and Forecast (2017-2027)
10.1.3. Parental
10.1.3.1. Market Revenue and Forecast (2017-2027)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2027)
Chapter 11. Global Generic Drugs Market, By Therapeutic Application
11.1. generic drugs Market, by Therapeutic Application, 2017-2027
11.1.1. Central nervous system (CNS)
11.1.1.1. Market Revenue and Forecast (2017-2027)
11.1.2. Cardiovascular
11.1.2.1. Market Revenue and Forecast (2017-2027)
11.1.3. Dermatology
11.1.3.1. Market Revenue and Forecast (2017-2027)
11.1.4. Oncology
11.1.4.1. Market Revenue and Forecast (2017-2027)
11.1.5. Respiratory
11.1.5.1. Market Revenue and Forecast (2017-2027)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2017-2027)
Chapter 12. Global Generic Drugs Market, By Distribution Channel
12.1. generic drugs Market, by Distribution Channel, 2017-2027
12.1.1. Hospitals Pharmacies
12.1.1.1. Market Revenue and Forecast (2017-2027)
12.1.2. Retail Pharmacies
12.1.2.1. Market Revenue and Forecast (2017-2027)
12.1.3. Others
12.1.3.1. Market Revenue and Forecast (2017-2027)
Chapter 13. Global Generic Drugs Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue Forecast by Drug Type(2017-2027)
13.1.2. Market Revenue Forecast by Brand (2017-2027)
13.1.3. Market Revenue Forecast by Route of Drug Administration (2017-2027)
13.1.4. Market Revenue Forecast by Therapeutic Application (2017-2027)
13.1.5. Market Revenue Forecast by Distribution Channel (2017-2027)
13.1.6. U.S
13.1.6.1. Market Revenue Forecast (2017-2027)
13.1.7. Canada
13.1.7.1. Market Revenue Forecast (2017-2027)
13.2. Europe
13.2.1. Market Revenue Forecast by Drug Type (2017-2027)
13.2.2. Market Revenue Forecast by Brand (2017-2027)
13.2.3. Market Revenue Forecast by Route of Drug Administration (2017-2027)
13.2.4. Market Revenue Forecast by Therapeutic Application (2017-2027)
13.2.5. Market Revenue Forecast by Distribution Channel (2017-2027)
13.2.6. UK
13.2.6.1. Market Revenue Forecast (2017-2027)
13.2.7. Germany
13.2.7.1. Market Revenue Forecast (2017-2027)
13.2.8. France
13.2.8.1. Market Revenue Forecast (2017-2027)
13.2.9. Rest of EU
13.2.9.1. Market Revenue Forecast (2017-2027)
13.3. Asia Pacific (APAC)
13.3.1. Market Revenue Forecast by Drug Type (2017-2027)
13.3.2. Market Revenue Forecast by Brand (2017-2027)
13.3.3. Market Revenue Forecast by Route of Drug Administration (2017-2027)
13.3.4. Market Revenue Forecast by Therapeutic Application (2017-2027)
13.3.5. Market Revenue Forecast by Distribution Channel (2017-2027)
13.3.6. China
13.3.6.1. Market Revenue Forecast (2017-2027)
13.3.7. India
13.3.7.1. Market Revenue Forecast (2017-2027)
13.3.8. Japan
13.3.8.1. Market Revenue Forecast (2017-2027)
13.3.9. Rest of APAC
13.3.9.1. Market Revenue Forecast (2017-2027)
13.4. LATAM
13.4.1. Market Revenue Forecast by Drug Type (2017-2027)
13.4.2. Market Revenue Forecast by Brand (2017-2027)
13.4.3. Market Revenue Forecast by Route of Drug Administration (2017-2027)
13.4.4. Market Revenue Forecast by Therapeutic Application (2017-2027)
13.4.5. Market Revenue Forecast by Distribution Channel (2017-2027)
13.4.6. Brazil
13.4.6.1. Market Revenue Forecast (2017-2027)
13.4.7. Rest of LATAM
13.4.7.1. Market Revenue Forecast (2017-2027)
13.5. Middle East and Africa (MEA)
13.5.1. Market Revenue Forecast by Drug Type (2017-2027)
13.5.2. Market Revenue Forecast by Brand (2017-2027)
13.5.3. Market Revenue Forecast by Route of Drug Administration (2017-2027)
13.5.4. Market Revenue Forecast by Therapeutic Application (2017-2027)
13.5.5. Market Revenue Forecast by Distribution Channel (2017-2027)
13.5.6. GCC
13.5.6.1. Market Revenue Forecast (2017-2027)
13.5.7. North Africa
13.5.7.1. Market Revenue Forecast (2017-2027)
13.5.8. South Africa
13.5.8.1. Market Revenue Forecast (2017-2027)
13.5.9. Rest of MEA
13.5.9.1. Market Revenue Forecast (2017-2027)
Chapter 14. Company Profiles
14.1. Abbott Laboratories
14.1.1. Company Overview, Business Information, Regional Presence
14.1.2. Product Portfolio Analysis
14.1.2.1. Product Details, Specification, Application
14.1.3. Revenue, Price, and Gross Margin (2017-2020)
14.1.4. Recent Developments and Strategies
14.2. Teva Pharmaceutical Industries Ltd.
14.2.1. Company Overview, Business Information, Regional Presence
14.2.2. Product Portfolio Analysis
14.2.2.1. Product Details, Specification, Application
14.2.3. Revenue, Price, and Gross Margin (2017-2020)
14.2.4. Recent Developments and Strategies
14.3. ALLERGAN
14.3.1. Company Overview, Business Information, Regional Presence
14.3.2. Product Portfolio Analysis
14.3.2.1. Product Details, Specification, Application
14.3.3. Revenue, Price, and Gross Margin (2017-2020)
14.3.4. Recent Developments and Strategies
14.4. Sandoz International GmbH
14.4.1. Company Overview, Business Information, Regional Presence
14.4.2. Product Portfolio Analysis
14.4.2.1. Product Details, Specification, Application
14.4.3. Revenue, Price, and Gross Margin (2017-2020)
14.4.4. Recent Developments and Strategies
14.5. Mylan N.V.
14.5.1. Company Overview, Business Information, Regional Presence
14.5.2. Product Portfolio Analysis
14.5.2.1. Product Details, Specification, Application
14.5.3. Revenue, Price, and Gross Margin (2017-2020)
14.5.4. Recent Developments and Strategies
14.6. STADA Arzneimittel AG
14.6.1. Company Overview, Business Information, Regional Presence
14.6.2. Product Portfolio Analysis
14.6.2.1. Product Details, Specification, Application
14.6.3. Revenue, Price, and Gross Margin (2017-2020)
14.6.4. Recent Developments and Strategies
14.7. Baxter International Inc.
14.7.1. Company Overview, Business Information, Regional Presence
14.7.2. Product Portfolio Analysis
14.7.2.1. Product Details, Specification, Application
14.7.3. Revenue, Price, and Gross Margin (2017-2020)
14.7.4. Recent Developments and Strategies
14.8. Eli Lilly and Company
14.8.1. Company Overview, Business Information, Regional Presence
14.8.2. Product Portfolio Analysis
14.8.2.1. Product Details, Specification, Application
14.8.3. Revenue, Price, and Gross Margin (2017-2020)
14.8.4. Recent Developments and Strategies
14.9. GlaxoSmithKline Plc.
14.9.1. Company Overview, Business Information, Regional Presence
14.9.2. Product Portfolio Analysis
14.9.2.1. Product Details, Specification, Application
14.9.3. Revenue, Price, and Gross Margin (2017-2020)
14.9.4. Recent Developments and Strategies
14.10. Pfizer Inc.
14.10.1. Company Overview, Business Information, Regional Presence
14.10.2. Product Portfolio Analysis
14.10.2.1. Product Details, Specification, Application
14.10.3. Revenue, Price, and Gross Margin (2017-2020)
14.10.4. Recent Developments and Strategies
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1205
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
